Fuminori Abe Selected Research

Fuminori Abe Research Topics

Disease

10	Neoplasms (Cancer) 07/2015 - 04/2008
2	Reperfusion Injury 02/2015 - 10/2013
2	Hematuria 09/2008 - 11/2006
2	Proteinuria 09/2008 - 11/2006
2	Glomerulonephritis 09/2008 - 11/2006
2	Leukemia 06/2003 - 12/2002
1	Obesity 09/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2015
1	Inflammation (Inflammations) 04/2014
1	Stomach Neoplasms (Stomach Cancer) 09/2012
1	Hyperthermia 03/2011
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2010
1	Vasculitis (Vasculitides) 09/2008
1	Esophageal Squamous Cell Carcinoma 04/2008
1	Hepatocellular Carcinoma (Hepatoma) 04/2008
1	Lung Neoplasms (Lung Cancer) 04/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2006
1	Lymphadenopathy 11/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2006
1	Experimental Arthritis 11/2004
1	Arthritis (Polyarthritis) 11/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2003
1	Acute Promyelocytic Leukemia 12/2002

Drug/Important Bio-Agent (IBA)

7	AcidsIBA 09/2015 - 03/2011
5	protoporphyrin IXIBA 07/2015 - 03/2011
4	Heme (Haem)IBA 04/2014 - 03/2011
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2013 - 03/2011
3	ubenimexIBA 06/2006 - 12/2002
2	Tumor Biomarkers (Tumor Markers)IBA 07/2015 - 12/2011
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2015 - 09/2012
2	EnzymesIBA 01/2010 - 01/2010
2	CytokinesIBA 01/2010 - 01/2010
2	Immunosuppressive Agents (Immunosuppressants)IBA 09/2008 - 11/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2008 - 11/2006
2	CD13 Antigens (Alanine Aminopeptidase)IBA 06/2006 - 12/2002
1	Biliverdine (Biliverdin)IBA 02/2015
1	Photosensitizing Agents (Photosensitizers)IBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	Carbon MonoxideIBA 10/2013
1	IronIBA 10/2013
1	Peptides (Polypeptides)IBA 09/2012
1	Adenosine Triphosphate (ATP)IBA 09/2012
1	Therapeutic UsesIBA 12/2011
1	PorphyrinsIBA 12/2011
1	Biological ProductsIBA 03/2011
1	Singlet OxygenIBA 03/2011
1	InterferonsIBA 01/2010
1	InterleukinsIBA 01/2010
1	LigandsIBA 01/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010
1	Tyrosine (L-Tyrosine)FDA Link 01/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2010
1	Sunitinib (Sutent)FDA Link 01/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	AntigensIBA 12/2008
1	VaccinesIBA 12/2008
1	Peroxidase (Myeloperoxidase)IBA 09/2008
1	EstersIBA 04/2008
1	Leucine (L-Leucine)FDA Link 04/2008
1	Apoptosis Regulatory ProteinsIBA 04/2008
1	Antigen-Antibody Complex (Immune Complex)IBA 11/2006
1	AutoantibodiesIBA 11/2006
1	Antinuclear AntibodiesIBA 11/2006
1	(S)- 1- (5- hydroxy- 1,5- dimethylhexyl)- 3- (7- (4- methoxyphenyl)- (1,2,4- triazolo(1,5- a)pyrimidin- 2- yl))ureaIBA 11/2006
1	Urea (Carbamide)FDA LinkGeneric 11/2006
1	NitrogenIBA 11/2006
1	N- (2- (4- methoxybenzenesulfonamide)phenyl)- 3,5- dimethyl- 4- isoxazolcarboxamideIBA 11/2004
1	Methotrexate (Mexate)FDA LinkGeneric 11/2004
1	Messenger RNA (mRNA)IBA 06/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2002
1	Immunologic Factors (Immunomodulators)IBA 12/2002

Therapy/Procedure

3	Photochemotherapy (Photodynamic Therapy) 07/2013 - 03/2011
3	Therapeutics 09/2012 - 06/2006
2	Oral Administration 12/2011 - 11/2006
1	Immunotherapy 03/2011
1	Radiotherapy 04/2008
1	Drug Therapy (Chemotherapy) 04/2008